Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05151471 |
|
Recruitment Status :
Terminated
(Futility Analysis of parent study MT-1186-A02 was met.)
First Posted : December 9, 2021
Last Update Posted : October 30, 2023
|
Sponsor:
Mitsubishi Tanabe Pharma America Inc.
Information provided by (Responsible Party):
Mitsubishi Tanabe Pharma America Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | September 29, 2023 |
| Actual Study Completion Date : | September 29, 2023 |